CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)

Market Cap	50.45B
Revenue (ttm)	2.06B
Net Income (ttm)	-86.05M
Shares Out	1.39B
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	113.22
Dividend	0.02 (0.05%)
Ex-Dividend Date	May 29, 2025

Volume	26,476,206
Average Volume	9,444,313
Open	39.25
Previous Close	39.25
Day's Range	35.62 - 39.31
52-Week Range	22.02 - 63.31
Beta	0.17
RSI	21.93
Earnings Date	Oct 28, 2025

About SHE:300765

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and biological enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2006
• Employees: 2,487
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300765

Financial Performance

In 2024, SHE:300765's revenue was 1.98 billion, a decrease of -21.98% compared to the previous year's 2.54 billion. Earnings were 53.73 million, a decrease of -87.63%.